SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Teva Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
340 21 0 TEVA
Emcee:  Prasanna L Soni Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
140 Teva been a roller coaster. They are mostly generic and getting more product anyosi s-1/14/1998
139 Reseach expectations are $3.28 for '98. Possible run into the 70's??? Gary105-1/14/1998
138 I would love to see TEVIY recover some of its lost ground, but this report willRPK-12/18/1997
137 Nice update from Lehman Bro. So why is the stock still sliding? Headline: TevUncle Mikey-12/17/1997
136 Controlled release drugs due just that, they control the release of the drug soRon Kline-12/16/1997
135 Ron - What are controlled release drugs?Uncle Mikey-12/16/1997
134 Thanks for the press release Gary. Looks like Teva is doing all the right thingRon Kline-12/16/1997
133 controlled release of generics biz.yahoo.comGary105-12/15/1997
132 Not really a strategic advantage. Basically this change is designed to align IsJames Silverman-11/25/1997
131 Potential major strategic advantage for TEVIY: biz.yahoo.comGary105-11/24/1997
130 Ron, pretty astute timing of your purchase. Right now it looks like teviy has Gary105-11/22/1997
129 Gary, I decided to add to my postition of Teva. I am down about 10 points fromRon Kline-11/17/1997
128 Doug, the best I can do is the following: 1. Consensus estimates: quote.yahoGary105-11/17/1997
127 Hi Gary: The estimates at lehmans (thru #114) are different from the ones touteDoug-11/16/1997
126 Nice move today, if teviy can move a couple of more points higher and hold for Gary105-11/15/1997
125 If I didn't already have a significant part of my "drug stock" alUncle Mikey-11/14/1997
124 Page 36 of Decembers Individual Investor (just out) quotes 2 analysts: Saks ofGary105-11/14/1997
123 I don't think they hype as much as say, H&Q. And I think their analysijay silberman-11/13/1997
122 I read some of the details from NatWest in the WSJ. Mostly it was the lack of Uncle Mikey-11/13/1997
121 Hi Gary: I would agree that this thread appears bullish but then many could be Doug-11/13/1997
120 In looking at teva's charts over the last 5 yrs it looks like each high hasGary105-11/13/1997
119 The most advanced project, I believe, is Rasagiline for Parkinsons, now in PhasLLLefty-11/13/1997
118 What really surprised me was that Copaxone counts for a full buck of that $3.50Uncle Mikey-11/13/1997
117 The analysis is certainly positive. They are predicting over $3.50/share in eaGary105-11/13/1997
116 Thanks Jay. There is a lot of good info on the Lehman site, but I wonder how mUncle Mikey-11/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News